Military Sexual Assault, Gender, and PTSD Treatment Outcomes of U.S. Veterans
Overview
Psychology
Affiliations
This study examined whether gender and military sexual assault (MSA) were associated with psychiatric severity differences at initiation of treatment for posttraumatic stress disorder (PTSD) and whether MSA and gender predicted psychiatric treatment outcomes. Male (n = 726) and female (n = 111) patients were recruited from 7 U.S. Department of Veterans Affairs (VA) PTSD specialty intensive treatment programs and completed an intake survey; 69% (n = 574) of the participants completed a 4-month postdischarge follow-up survey. Measures included current PTSD and depressive symptoms, aggressive/violent behaviors, alcohol and drug use severity, and quality of life. Multilevel multivariate regression analyses were conducted to examine the main and interaction effects of gender and MSA on psychiatric treatment outcomes at 4-month follow-up, including demographics, baseline severity, hostile fire, and treatment length of stay. Baseline PTSD severity did not differ by gender or MSA status, but women had more severe depressive symptoms (d = 0.40) and less aggressive/violent symptoms (d = -0.46) than men. Gender, MSA status, and the interaction between gender and MSA did not predict treatment outcomes as hypothesized. Male and female veterans with and without MSA responded equally well to treatment in VA PTSD intensive treatment programs.
Kerr K, Mellor R, Bennett D, Wellauer R, McGaw V Aust N Z J Psychiatry. 2024; 59(1):40-47.
PMID: 39465995 PMC: 11667955. DOI: 10.1177/00048674241289027.
Zhang J, Wang J, Liu J, Guo Q, Lin J, Shen Y Psychiatry Investig. 2023; 20(11):1045-1053.
PMID: 37997332 PMC: 10678149. DOI: 10.30773/pi.2023.0089.
Hunt C, Casas B, Chiu P, Smith L, Priorello L, Lee K Cogn Behav Ther. 2023; 53(1):70-86.
PMID: 37969001 PMC: 10842083. DOI: 10.1080/16506073.2023.2268277.
Hahn C, Jarnecke A, Calhoun C, Melkonian A, Flanagan J, Back S Mil Psychol. 2022; 34(1):12-22.
PMID: 35340543 PMC: 8942369. DOI: 10.1080/08995605.2021.1964901.
Lofgreen A, Tirone V, Carroll K, Rufa A, Smith D, Bagley J J Affect Disord. 2020; 269:134-140.
PMID: 32250866 PMC: 7364442. DOI: 10.1016/j.jad.2020.03.036.